Artemis Medicare Services Ltd

Artemis Medicare Services Ltd

₹ 170 -0.82%
28 Mar - close price
About

Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 318-bedded multi-specialty tertiary care hospital in Gurgaon. It has specialization in various segments like Orthopedics & Joint Replacement, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. AMSL has been awarded with the NABH accreditation.

Key Points

Specialization-wise revenue break-up:
The revenue stream of AMSL remained well diversified in FY22.
1) Orthopaedics & Joint Replacement contributing (13%)
2) Oncology contributing (18%)
3) Cardiovascular contributing (10%)
4) Neuorologyeurosciences & some others together contributing( 17%)
5) Others incl. Medicine,Gynae,Nephrology etc (42%) [1]

  • Market Cap 2,308 Cr.
  • Current Price 170
  • High / Low 194 / 63.5
  • Stock P/E 50.6
  • Book Value 31.3
  • Dividend Yield 0.26 %
  • ROCE 11.4 %
  • ROE 10.1 %
  • Face Value 1.00

Pros

Cons

  • Stock is trading at 5.43 times its book value
  • The company has delivered a poor sales growth of 7.28% over past five years.
  • Company has a low return on equity of 7.48% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
122 127 120 136 142 146 163 182 181 187 201 217 210
106 107 108 117 124 129 144 158 156 163 174 184 179
Operating Profit 16 20 13 20 18 17 19 24 26 25 27 33 32
OPM % 13% 16% 11% 14% 13% 12% 12% 13% 14% 13% 14% 15% 15%
1 5 1 1 1 1 2 1 1 2 1 2 2
Interest 3 2 2 2 3 4 4 5 5 5 6 7 8
Depreciation 5 5 5 5 5 6 6 7 8 8 9 9 10
Profit before tax 9 17 7 13 10 8 11 14 14 14 13 19 16
Tax % 37% 26% 39% 36% 36% -57% 22% 31% 23% 23% 26% 27% 29%
5 13 4 8 7 13 9 10 11 10 10 14 12
EPS in Rs 0.41 0.97 0.31 0.63 0.51 1.01 0.65 0.73 0.80 0.78 0.73 1.01 0.85
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
189 217 261 368 402 459 503 547 563 402 545 714 815
166 194 234 325 359 406 442 480 501 367 477 620 699
Operating Profit 23 23 27 43 43 53 60 66 62 35 68 94 117
OPM % 12% 10% 11% 12% 11% 11% 12% 12% 11% 9% 12% 13% 14%
2 2 1 3 5 4 3 2 4 7 3 7 8
Interest 16 15 13 12 9 9 9 11 13 12 11 19 26
Depreciation 9 9 9 12 12 15 18 20 22 21 21 29 36
Profit before tax 0 0 7 21 27 32 35 37 32 9 39 53 62
Tax % 17% 0% 0% 12% 21% 16% 24% 44% 36% 20% 16% 25%
0 0 7 19 22 27 27 21 20 7 33 40 46
EPS in Rs 0.01 0.02 0.32 0.88 1.03 1.29 1.27 0.98 1.54 0.54 2.46 2.96 3.37
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 15%
Compounded Sales Growth
10 Years: 13%
5 Years: 7%
3 Years: 8%
TTM: 21%
Compounded Profit Growth
10 Years: 59%
5 Years: 7%
3 Years: 24%
TTM: 7%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 97%
1 Year: 162%
Return on Equity
10 Years: 9%
5 Years: 8%
3 Years: 7%
Last Year: 10%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 21 21 21 21 21 21 21 0 13 13 13 13 14
Reserves 109 109 116 135 163 183 210 280 301 308 348 393 411
121 118 110 85 68 94 91 114 108 137 190 268 306
33 39 66 90 93 124 130 160 159 130 145 207 205
Total Liabilities 284 287 313 331 345 422 452 555 581 589 697 882 937
239 237 236 239 249 283 309 381 387 372 476 584 659
CWIP 0 0 0 0 1 27 43 49 56 81 64 95 54
Investments 0 0 0 0 0 0 0 0 2 4 6 12 15
45 50 77 91 94 112 100 124 137 132 152 192 208
Total Assets 284 287 313 331 345 422 452 555 581 589 697 882 937

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
7 22 45 53 20 58 72 41 56 27 61 129
4 -5 -12 -10 -14 -74 -67 -50 -22 -34 -106 -153
-13 -18 -21 -35 -24 19 -10 14 -33 13 44 30
Net Cash Flow -3 -1 11 7 -18 3 -4 5 2 6 -2 7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 45 40 41 39 49 48 40 52 50 48 47 43
Inventory Days 32 26 26 26 21 19
Days Payable 99 144 237 195 189 187
Cash Conversion Cycle -22 -78 -171 -129 -120 -120 40 52 50 48 47 43
Working Capital Days 2 -9 -70 -59 -31 -44 -53 -26 -28 -15 -10 -29
ROCE % 6% 6% 8% 14% 15% 16% 15% 14% 11% 4% 10% 11%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
69.82% 69.82% 69.82% 69.82% 69.82% 69.59% 69.27% 68.91% 68.91% 68.03% 68.03% 68.03%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 0.09% 0.11%
1.22% 1.22% 1.22% 1.22% 1.10% 0.91% 0.90% 1.15% 1.37% 1.41% 1.51% 1.96%
7.37% 7.37% 7.37% 7.37% 7.37% 7.34% 7.31% 7.27% 7.27% 7.18% 7.18% 7.18%
21.59% 21.59% 21.59% 21.59% 21.71% 22.17% 22.53% 22.65% 22.43% 23.30% 23.18% 22.72%
No. of Shareholders 5,2736,01010,76512,82712,09815,17714,63717,99518,10019,08220,52922,375

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents